The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) was $22.62 for the day, up 0.89% from the previous closing price of $22.42. In other words, the price has increased by $0.89 from its previous closing price. On the day, 5.6 million shares were traded. TEVA stock price reached its highest trading level at $22.8 during the session, while it also had its lowest trading level at $22.28.
Ratios:
Our analysis of TEVA’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.73 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 9.37. For the most recent quarter (mrq), Quick Ratio is recorded 0.61 and its Current Ratio is at 0.89. In the meantime, Its Debt-to-Equity ratio is 3.18 whereas as Long-Term Debt/Eq ratio is at 2.75.
On March 08, 2024, JP Morgan Upgraded its rating to Neutral which previously was Underweight but kept the price unchanged to $14.
Piper Sandler Upgraded its Neutral to Overweight on February 12, 2024, whereas the target price for the stock was revised from $12 to $19.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 20 ’24 when MIGNONE ROBERTO sold 286,000 shares for $22.01 per share. The transaction valued at 6,294,031 led to the insider holds 695,000 shares of the business.
Bridger Management, LLC (1) bought 286,000 shares of TEVA for $6,094,660 on Dec 20 ’24. On Nov 20 ’24, another insider, Fox Christine, who serves as the EVP, Head of U.S. Commercial of the company, sold 19,388 shares for $16.87 each. As a result, the insider received 327,085 and left with 44,104 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TEVA now has a Market Capitalization of 25629591552 and an Enterprise Value of 41304080384. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.53 while its Price-to-Book (P/B) ratio in mrq is 4.23. Its current Enterprise Value per Revenue stands at 2.463 whereas that against EBITDA is 8.63.
Stock Price History:
Over the past 52 weeks, TEVA has reached a high of $22.50, while it has fallen to a 52-week low of $10.34. The 50-Day Moving Average of the stock is 25.02%, while the 200-Day Moving Average is calculated to be 34.93%.
Shares Statistics:
TEVA traded an average of 8.09M shares per day over the past three months and 15648120 shares per day over the past ten days. A total of 1.13B shares are outstanding, with a floating share count of 1.13B. Insiders hold about 0.01% of the company’s shares, while institutions hold 56.88% stake in the company. Shares short for TEVA as of 1732838400 were 22407656 with a Short Ratio of 2.87, compared to 1730332800 on 18094518. Therefore, it implies a Short% of Shares Outstanding of 22407656 and a Short% of Float of 1.9900000000000002.
Dividends & Splits
The stock’s 5-year Average Dividend Yield is 2.95.
